Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
SHISEIDO SHEER AND PERFECT COMPACT (REFILL)
- Manufacturer
- SHISEIDO AMERICAS CORPORATION | SHISEIDO AMERICA INC.
- Effective date
- 2018-12-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:40:40
Label at a glance#
ProductSHISEIDO SHEER AND PERFECT COMPACT (REFILL) I00
Active ingredientOCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE
Label structure26 sections
Dosage and administration
For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the su...
Storage and handling
protect this product in this container from excessive heat and direct sun.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| OCTINOXATE 2.9% | Sunscreen |
| OCTOCRYLENE 2.0% | Sunscreen |
| TITANIUM DIOXIDE 6.2% | Sunscreen |
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
Inactive Ingredients
TALC ∙ SYNTHETIC FLUORPHLOGOPITE ∙ NYLON-12 ∙ POLYMETHYL METHACRYLATE ∙ SILICA ∙ VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER ∙ METHYL METHACRYLATE CROSSPOLYMER ∙ CETYL ETHYLHEXANOATE ∙ SORBITAN SESQUIISOSTEARATE ∙ DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE ∙ PEG/PPG-36/41 DIMETHYL ETHER ∙ ALUMINUM HYDROXIDE ∙ ALUMINUM DISTEARATE ∙ TRIETHOXYSILYLETHYL POLYDIMETHYLSILOXYETHYL HEXYL DIMETHICONE ∙ METHICONE ∙ CALCIUM STEARATE ∙ HYDROGEN DIMETHICONE ∙ POLYSILICONE-2 ∙ TOCOPHEROL ∙ BARIUM SULFATE ∙ CITRIC ACID ∙ SODIUM PHOSPHATE ∙ BHT ∙ TETRADECENE ∙ ALUMINA ∙ CHLORPHENESIN ∙ MICA ∙ BISMUTH OXYCHLORIDE ∙ TITANIUM DIOXIDE ∙ IRON OXIDES ∙ ZINC OXIDE ∙
Other information
- protect this product in this container from excessive heat and direct sun.
Questions or comments?
Call toll free 1-800-906-7503
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - I 00
SHI SEIDO
I 00
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - I 20
SHI SEIDO
I 20
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - I 40
SHI SEIDO
I 40
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - I 60
SHI SEIDO
I 60
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - I 100
SHI SEIDO
I 100
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - B 00
SHI SEIDO
B 00
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - B 20
SHI SEIDO
B 20
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - B 40
SHI SEIDO
B 40
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - B 60
SHI SEIDO
B 60
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - B 100
SHI SEIDO
B 100
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - O 00
SHI SEIDO
O 00
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - O 20
SHI SEIDO
O 20
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - O 40
SHI SEIDO
O 40
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - O 60
SHI SEIDO
O 60
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - O 80
SHI SEIDO
O 80
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - D 10
SHI SEIDO
D 10
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - D 20
SHI SEIDO
D 20
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
PRINCIPAL DISPLAY PANEL - 10 g Tray Carton - D 30
SHI SEIDO
D 30
Sheer and Perfect
Compact (Refill)
Evens tone, Smoothes pores,
Oil-free
BROAD SPECTRUM
SPF 21
sunscreen
10g NET WT. .35 OZ.
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| ALUMINUM DISTEARATE | INACTIVE INGREDIENT | 7P1HP1B9UI | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| BARIUM SULFATE | INACTIVE INGREDIENT | 25BB7EKE2E | 1 | |
| BISMUTH OXYCHLORIDE | INACTIVE INGREDIENT | 4ZR792I587 | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | 1 | |
| CETYL ETHYLHEXANOATE | INACTIVE INGREDIENT | 134647WMX4 | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE | INACTIVE INGREDIENT | 74J1X57U42 | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| METHICONE (20 CST) | INACTIVE INGREDIENT | 6777U11MKT | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 1 | |
| PEG/PPG-36/41 DIMETHYL ETHER | INACTIVE INGREDIENT | GZ406N3R9F | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM PHOSPHATE | INACTIVE INGREDIENT | SE337SVY37 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TETRADECENE | INACTIVE INGREDIENT | FW23481S7S | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Products#
Every source-derived product name is available through these pages.
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) I00
- OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE
- TALC
- NYLON-12
- SILICON DIOXIDE
- CETYL ETHYLHEXANOATE
- DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE
- PEG/PPG-36/41 DIMETHYL ETHER
- ALUMINUM HYDROXIDE
- ALUMINUM DISTEARATE
- METHICONE (20 CST)
- CALCIUM STEARATE
- .ALPHA.-TOCOPHEROL
- BARIUM SULFATE
- CITRIC ACID MONOHYDRATE
- SODIUM PHOSPHATE
- BUTYLATED HYDROXYTOLUENE
- TETRADECENE
- ALUMINUM OXIDE
- CHLORPHENESIN
- MICA
- BISMUTH OXYCHLORIDE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- ZINC OXIDE
- OCTINOXATE
- OCTOCRYLENE
- TITANIUM DIOXIDE
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) I20
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) I40
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) I60
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) I100
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) B00
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) B20
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) B40
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) B60
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) B100
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) O00
- SHISEIDO SHEER AND PERFECT COMPACT (REFILL) O20
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | OINTMENT / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, EXTENDED RELEASE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| CALCIUM STEARATE | CALCIUM STEARATE | 776XM7047L | TABLET, EXTENDED RELEASE / ORAL | 36 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRAVENOUS | 10.6 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, DELAYED RELEASE / ORAL | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | MOUTHWASH / BUCCAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, EXTENDED RELEASE / ORAL | 0.03 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / SUBLINGUAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOAP / TOPICAL | 0.02 %w/w | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION, SOLUTION / INTRAVENOUS | 0.14 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / SUBCUTANEOUS | 0.38 %w/v | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GUM, CHEWING / BUCCAL | 5 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| CALCIUM STEARATE | CALCIUM STEARATE | 776XM7047L | TABLET, FILM COATED / ORAL | 16 mg | ||
| BARIUM SULFATE | BARIUM SULFATE | 25BB7EKE2E | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1dac0e2b-760a-480a-a418-ee5c8837f720 | f956286f-1ce0-4d49-95ef-c63b6e6ce8d4 | 2023-10-20 | Warnings | f956286f-1ce0-4d49-95ef-c63b6e6ce8d4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.